Feature

Can a nationwide liver paired donation program work?


 

Is a national liver paired donor program feasible?

While the UNOS pilot program offers financial assistance for expenses related to liver donation, some transplant surgeons are skeptical about the potential travel component of the pilot program.

The pilot program requires that the donor bring one support person if there is a need to travel for the surgery, but undergoing major abdominal surgery from a transplant team they are not familiar with may be stressful, said Peter Abt, MD, a transplant surgeon at the Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia. “That’s a big ask,” he said, “and I’m not sure many potential donors would be up to that.”

John Roberts, MD, a transplant surgeon at the University of California, San Francisco, agreed that the travel component may put additional stress on the donor, but “if it’s the only way for the recipient to get a transplant, then the donor might be motivated,” he added.

Dr. Jackson remains optimistic. “Our experience so far has been that, yes, some people have been hesitant for things like traveling, but a lot of people who seem to be genuinely dedicated to the idea of living donation have been very enthusiastic,” she noted.

Dr. Leishman agreed that the travel aspect appears to one of the greatest barriers to participants entering the program but noted that a goal of the pilot program is to understand better what works - and what doesn’t – when considering a liver paired donation program on a national scale. “[Our] steering committee has put together a really nice framework that they think will work, but they know it’s not perfect. We’re going to have to tweak it along the way,” she said.

More information on the paired liver donation pilot program can be found on the UNOS website.

The sources interviewed for this article reported no financial conflicts of interest.

A version of this article first appeared on Medscape.com.

This article was updated 2/15/23.

Pages

Recommended Reading

Midodrine may be comparable to albumin for PICD prevention in ACLF
MDedge Internal Medicine
Poor NAFLD outcomes with increased VCTE-measured liver stiffness
MDedge Internal Medicine
How a cheap liver drug may be the key to preventing COVID
MDedge Internal Medicine
A bold national plan to eliminate HCV by 2050
MDedge Internal Medicine
Direct-acting antivirals tied to better outcomes in chronic Hep C
MDedge Internal Medicine
Liver cancer exacts high financial toll on older adults
MDedge Internal Medicine
Nonheavy alcohol use associated with liver fibrosis, NASH
MDedge Internal Medicine
Strong support to provide DAA therapy to all patients with HCV
MDedge Internal Medicine
Components of coffee other than caffeine linked to reduced NAFLD severity
MDedge Internal Medicine
FAST score appears accurate for diagnosis of fibrotic NASH
MDedge Internal Medicine